Skip to NavigationSkip to content

Pharmafile - Research and Development News

Genentech and Roche have released new Phase 3 on the efficacy of their immunotheraoy drug Tecentriq (atezolizumab), when used in combination with...
Eli Lilly has shared new phase 3 data on Verzenio (abemaciclib), in combination with endocrine therapy (ET) following surgery, showing the combo met...
Hope is waning around the efficacy of Roche’s Actemra (tocilizumab) following the release of results from an Italian study focusing on the use of the...
The FDA has awarded approval to Jazz Pharma and PharmaMar for Zepzelca (lurbinectedin) as a treatment for metastatic small cell lung cancer (SCLC) in...
The Diabetes Prevention Program Outcomes Study (DPPOS) of 2,000 people showed a significant reduction in the participants’ risk of developing type 2...
The University of Oxford has unveiled exciting new data in the treatment of the novel coronavirus, with a randomised clinical trial proving the...
There is a fear of a second wave of coronavirus coming out of China, as the country reported its highest amount of cases in months as a new outbreak...
The HPV (human papillomavirus) vaccine Gardasil 9 has been approved by the FDA to prevent HPV-related genital tract, agnogenital infections and...
As more than 130 efforts to develop an effective vaccine against the novel coronavirus continue to roll on, Beijing-based firm Sinovac has revealed...
Janssen has revealed new data on its interleukin (IL)-23 inhibitor Tremfya (guselkumab) at the American Academy of Dermatology (AAD) virtual event...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches